Skip to main content

Carotid Artery Stenosis

0
Pipeline Programs
9
Companies
9
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

9 companies ranked by most advanced pipeline stage

InspireMD
InspireMDIsrael - Tel Aviv
2 programs
CGuard Carotid Stent implantationN/A1 trial
SwitchGuardTM NPSN/A1 trial
Active Trials
NCT04900844Active Not Recruiting317Est. Oct 2025
NCT07277296Not Yet Recruiting103Est. Feb 2028
Contego Medical
Contego MedicalNC - Raleigh
1 program
Carotid artery stenting with Neuroguard IEP SystemN/A
IQVIA
IQVIADURHAM, NC
1 program
Carotid artery stenting with Neuroguard IEP SystemN/A1 trial
Active Trials
NCT04201132Active Not Recruiting305Est. Dec 2025
UNION therapeutics
UNION therapeuticsDenmark - Hellerup
1 program
Carotid revascularizationN/A1 trial
Active Trials
NCT05629000Recruiting1,000Est. Dec 2026
Abbott
AbbottABBOTT PARK, IL
1 program
Emboshield NAV6® embolic protection systemN/A1 trial
Active Trials
NCT01550835Unknown80
Cordis
CordisFL - Miami Lakes
1 program
PRECISE PRO Rx Nitinol Stent SystemN/A1 trial
Active Trials
NCT07204678Completed199Est. Feb 2026
Integra LifeSciences
Integra LifeSciencesAustralia - Clayton
1 program
Sundt carotid shuntN/A1 trial
Active Trials
NCT03816202Completed100Est. Aug 2019
Boston Scientific
Boston ScientificCA - Valencia
1 program
transcarotid artery revascularizationN/A1 trial
Active Trials
NCT07458243Not Yet Recruiting60Est. Sep 2027
Providence Therapeutics
1 program
Carotid Stent with Distal Protection DevicePHASE_31 trial
Active Trials
NCT00318851Completed62Est. Aug 2007

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
2028
Providence TherapeuticsCarotid Stent with Distal Protection Device
Boston Scientifictranscarotid artery revascularization
InspireMDSwitchGuardTM NPS
CordisPRECISE PRO Rx Nitinol Stent System
InspireMDCGuard Carotid Stent implantation
IQVIACarotid artery stenting with Neuroguard IEP System
Integra LifeSciencesSundt carotid shunt
UNION therapeuticsCarotid revascularization
AbbottEmboshield NAV6® embolic protection system

Clinical Trials (9)

Total enrollment: 2,226 patients across 9 trials

NCT00318851Providence TherapeuticsCarotid Stent with Distal Protection Device

Carotid Artery Stenting With Protection Registry

Start: Sep 2003Est. completion: Aug 200762 patients
Phase 3Completed
NCT07458243Boston Scientifictranscarotid artery revascularization

Registry of ENROUTE NPS in Conjunction With Carotid WALLSTENT

Start: Oct 2026Est. completion: Sep 202760 patients
N/ANot Yet Recruiting
NCT07277296InspireMDSwitchGuardTM NPS

CGUARDIANS III IDE Pivotal Trial

Start: Jan 2026Est. completion: Feb 2028103 patients
N/ANot Yet Recruiting
NCT07204678CordisPRECISE PRO Rx Nitinol Stent System

PMCF Study of Precise Pro Rx for Carotid Artery Disease

Start: Oct 2025Est. completion: Feb 2026199 patients
N/ACompleted
NCT04900844InspireMDCGuard Carotid Stent implantation

Safety and Efficacy of the CGuard™ Carotid Stent System in Carotid Artery Stenting

Start: Jul 2021Est. completion: Oct 2025317 patients
N/AActive Not Recruiting
NCT04201132IQVIACarotid artery stenting with Neuroguard IEP System

Protection Against Emboli During Carotid Artery Stenting Using the Neuroguard IEP System

Start: Jun 2020Est. completion: Dec 2025305 patients
N/AActive Not Recruiting
NCT03816202Integra LifeSciencesSundt carotid shunt

Sundt™ Carotid Shunt Retrospective Post Market Clinical Follow-up Study (PMCF)

Start: Apr 2019Est. completion: Aug 2019100 patients
N/ACompleted
NCT05629000UNION therapeuticsCarotid revascularization

Optimization Strategy of Carotid Artery Stenosis

Start: Jan 2015Est. completion: Dec 20261,000 patients
N/ARecruiting
NCT01550835AbbottEmboshield NAV6® embolic protection system

Impact of Aspiration Thrombectomy During Carotid Stenting

Start: Feb 201280 patients
N/AUnknown

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 actively recruiting trials targeting 2,226 patients
9 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.